Traitement en cours...
Publications

2008

STX140 is efficacious in vitro and in vivo in taxane-resistant breast carcinoma cells (2008); Newman et al.; Clin Cancer Res; 14(2): 597.
Clic here
[Agendas]
2010 BIO International Convention - Chicago
3-6 May 2010
to know more
AACR, Washington
17-21 April 2010
to know more
2010 Bio Europe Spring - Barcelona
8-10 March 2010
to know more
[News & Press]
XenTech revamps its logo
May 2010
to know more
Appointment of Sabrina Serpillon as
February 2010
to know more
XenTech appoints Bertrand Coulomb as
May 2009
to know more
[Publication]
ASPM-associated
11 January 2010
to know more
STX140 is efficacious in vitro and in vivo
15 January 2008
to know more
A new model of patient tumor-derived breast cancer
2007
to know more

Design by Ineiaki | Sitemap | Terms of use